In a prospective study carried out at 13 sites in 3 European countries between August 2009 and October 2010 , White , non-pregnant , premenopausal women with bacterial vaginosis were randomly assigned to receive rifaximin at 100mg for 5 days ( 100mg/5 days ) , 25mg/5 days , or 100mg/2 days , or placebo .
